2020
DOI: 10.1021/acs.bioconjchem.0c00375
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis, Conjugation, and Reactivity of Novel trans,trans-1,5-Cyclooctadiene-Derived Bioorthogonal Linkers

Abstract: The tetrazine/trans-cyclooctene (TCO) inverse electron-demand Diels−Alder (IEDDA) reaction is the fastest bioorthogonal "click" ligation process reported to date. In this context, TCO reagents have found widespread applications; however, their availability and structural diversity is still somewhat limited due to challenges connected with their synthesis and structural modification. To address this issue, we developed a novel strategy for the conjugation of TCO derivatives to a biomolecule, which allows for th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 40 publications
0
5
0
Order By: Relevance
“…[16] The reaction between tetrazines and transcyclooctene (TCO) is one of the most efficient click reactions reported to date, with demonstrated utility in animal models systems. [17][18][19][20][21][22][23][24] Tetrazine and TCO react irreversibly and specifically in vivo with a high thermodynamic driving force, with minimal interaction with the surrounding biological mileu. [25,26] The CAPAC Platform uses a tetrazine-modified biopolymer injected at the tumor that can capture a systemically circulating TCO-modified protodrug, to precisely release the active drug at the tumor.…”
Section: Introductionmentioning
confidence: 99%
“…[16] The reaction between tetrazines and transcyclooctene (TCO) is one of the most efficient click reactions reported to date, with demonstrated utility in animal models systems. [17][18][19][20][21][22][23][24] Tetrazine and TCO react irreversibly and specifically in vivo with a high thermodynamic driving force, with minimal interaction with the surrounding biological mileu. [25,26] The CAPAC Platform uses a tetrazine-modified biopolymer injected at the tumor that can capture a systemically circulating TCO-modified protodrug, to precisely release the active drug at the tumor.…”
Section: Introductionmentioning
confidence: 99%
“…The chemistry allowed less-tedious chemical modification of TCO and was exploited by Longo et al to prepare several TCO derivatives for live-cell fluorescent imaging. However, the kinetics of 17 were too slow for an in vivo pretargeting study [ 80 ]. So far, and to the best of our knowledge, no other dienophiles than 5-OH-TCO have been successfully advanced to in vivo pretargeting studies.…”
Section: Dienophilesmentioning
confidence: 99%
“… ( A ) Represented dienophiles for IEDDA reaction: 11 [ 75 ], 12 – 15 [ 77 ], 16 [ 78 ], 17 [ 80 ]. ( B ) Modified dienophiles for antibody-based pretargeting studies.…”
Section: Figurementioning
confidence: 99%
“…The second order rate constant of the IEDDA between TCO and Tz could be over 10 5 M −1 s −1 , [135b] making it the fastest type of bioorthogonal reactions reported to date. A TCO analog that is derived from trans , trans ‐1,5‐cyclooctadiene [(E,E)‐COD] was recently reported, [136] which, other than being competent in bioconjugation, offers an appealing new synthesis to the core structure of TCO. In addition to strained alkenes, vinyl boronic acid (VBA) could engage in a bioorthogonal IEDDA with Tz (Figure 11c) [137] .…”
Section: Bioorthogonal Chemistrymentioning
confidence: 99%